Cell Therapy

The silent corridors of the state-of-the-art Killarney Community Nursing Unit stand in stark contrast to the overcrowded conditions found in the aging facility it was meticulously designed to replace. While the physical structure is complete and ready to welcome its first residents, a deep-seated

The biological resilience of pancreatic ductal adenocarcinoma (PDAC) has long earned it a reputation as the "impenetrable fortress" of oncology, maintaining a lethal grip on patients despite decades of intensive global research. While the discovery of ferroptosis—a specialized, iron-dependent form

The human immune system operates like a sophisticated military intelligence network, yet even the most advanced radar systems can fail if their power supply is severed at the source. For years, the global struggle against malignancy focused primarily on unmasking cancer cells, assuming that once

The landscape of modern oncology is currently witnessing a tectonic shift as clinical researchers increasingly abandon the cumbersome laboratory-based cell modification protocols that have defined the last decade. For several years, the medical community viewed Chimeric Antigen Receptor (CAR)

Inside the microscopic battlefield of a human tumor, the difference between a patient’s recovery and a lethal progression often hinges on the metabolic stamina of a single type of immune cell. In the high-stakes battle against malignancy, the CD8+ T cell acts as the body’s elite soldier, but even

Ivan Kairatov is a leading figure in the biopharmaceutical landscape, recognized for his extensive contributions to the research and development of implantable medical technologies. With a career spanning the intersection of materials science and biotechnology, he has dedicated his expertise to